Harnessing the Power of Engagement in Patient-Focused Drug Development
About Us
Who We Are & What We Do
CONGREDIOR:
A Latin word meaning "to meet," "to approach," "to engage."
PEO:
An abbreviation for "Patient Engagement Optimization."
At CongrediorPEO, we harness the power of engagement to optimize Patient-focused Drug Development.
We are experts in bringing pharmaceutical/biotech companies and clinical research organizations together with patient communities to optimize patient-focused drug development initiatives. From global advisory boards, focus groups, and surveys to pre- and post-launch marketing initiatives, patient voices are essential to the success of new drug development.
The team at CongrediorPEO has 40+ years of combined experience in creating, managing, and optimizing
patient engagement solutions.
Our Services
Protocol Reviews
Patient Advisory Boards
In early clinical trial design, it is esssential to gain the perspectives and insights of the patients who will eventually enroll in a clinical trial. We initiate early-stage protocol reviews with patient populations to guide protocol developmet for optimum clinical trial recruitment success.
Patient Advisory Boards
Patient Advisory Boards
We excel at creating Patient Advisory Boards populated by patients and thought leaders. Insights from PABs are vital to clinical trial design and all patient-facing materials and media. Whether it is a global, national, or regional PAB, we mange every aspect of
in-person, remote, and hybrid meetings, working closely with clients' marketing/legal/regulatory processes.
Focus Groups & Surveys
Recruiting Patient Ambassadors
From formulary preferences to packaging, patients provide critical insights into how a therapy can best meet the needs of end-users. Focus groups and surveys are important tools to gain critical insights that lead to successful treatment opportunities. We work with patient organizations and other thought leaders to recruit focus group members, as well as develop and disseminate surveys.
Recruiting Patient Ambassadors
Recruiting Patient Ambassadors
The voice of the patient is a powerful tool to help drug makers gain inroads into clinical trial enrollment, as well as pre- and post-launch awareness initiatives. Our expertise in recruiting and training patient ambassadors helps our clients gain critical exposure within their target patient population.
Regulatory Agency Engagement Preperation
Patient Organization Relationship Management
Working closely with our pharmaceutical/biotech clients, we help identify and prepare patient experts and thought leaders to provide input at FDA Patient Listening Sessions and other regulatory agency meetings.
Patient Organization Relationship Management
Patient Organization Relationship Management
Engaging with patient organizations that represent a particular disease cohort is key to successful engagement initiatives. The team at CongrediorPEO has more than 20 years of nonprofit management and engagement experience. Such experience makes our company the ideal partner to manage the intricacies of PO and pharmaceutical/biotech industry relations.
Patient Organization Services
Patient Organization Services
Patient Organization Services
We proudly work with small and medium sized nonprofit patient organizations. We specialize in developing strategies and programs that prepare organizations to engage in patient-focused drug development partnerships with the pharmaceutical/biotech industry.
Reducing Barriers. Building Trust. Improving Health.
We believe that diversity in patient-focused drug development leads to better science, improved patient outcomes, and a healthier society.
That's why CongrediorPEO is committed to fostering diversity and inclusion in all aspects of patient-focused drug development. Our mission to connect pharmaceutical/biotech companies, CROs, and patient communities includes actively seeking participants from a wide range of backgrounds, including race, ethnicity, gender, age, and socioeconomic status.
Reducing barriers to participation builds trust within traditionally underrepresented communities. We are dedicated to partnering with companies, patient organizations, and advocacy groups to ensure that our patient engagement initiatives are equitable and inclusive.
